snyderman nancy lynn MD

CIK 00016751984 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001675198

Recent Transactions

50 trades

Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2025-05-31−8,013→ 0 total
Exercise/Conversion
Alkermes plc.$ALKS
Ordinary Shares
2025-05-31+8,013→ 12,652 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2025-05-31$30.61/sh−1,924→ 10,728 total
Award
Alkermes plc.$ALKS
Restricted Stock Unit Award
2025-05-21+6,142→ 6,142 total
Award
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2025-05-21+13,474→ 13,474 total
Award
Lyra Therapeutics, Inc.$LYRA
Restricted Stock Units
2025-05-14+32,000→ 32,000 total
Gift
Axonics, Inc.
Common Stock
2024-11-07−5,000→ 14,944 total
Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2024-06-29−6,104→ 0 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2024-06-29$24.10/sh−1,465→ 4,639 total
Exercise/Conversion
Alkermes plc.$ALKS
Ordinary Shares
2024-06-29+6,104→ 6,104 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2024-06-13+30,000→ 30,000 total
Award
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2024-05-31+17,492→ 17,492 total
Award
Alkermes plc.$ALKS
Restricted Stock Unit Award
2024-05-31+8,013→ 8,013 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$44.75/sh+350→ 17,850 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$46.72/sh+548→ 27,948 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$57.11/sh+284→ 14,484 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$46.72/sh+324→ 16,524 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$16.52/sh+256→ 13,079 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$18.45/sh+230→ 11,739 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$30.72/sh+254→ 12,986 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$30.86/sh+231→ 11,785 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$24.55/sh+448→ 22,848 total
Other
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-11-17$24.24/sh+313→ 15,990 total
Other
Alkermes plc.$ALKS
Restricted Stock Unit Award
2023-11-17+119→ 6,104 total
Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2023-07-07−5,957→ 0 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2023-07-07$29.88/sh−1,430→ 20,783 total
Exercise/Conversion
Alkermes plc.$ALKS
Ordinary Shares
2023-07-07+5,957→ 22,213 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2023-06-30+20,000→ 20,000 total
Award
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2023-06-29+12,732→ 12,732 total
Award
Alkermes plc.$ALKS
Restricted Stock Unit Award
2023-06-29+5,985→ 5,985 total
Award
Axonics, Inc.
Common Stock
2023-06-26+3,000→ 19,944 total
Award
Axonics, Inc.
Common Stock
2022-08-18+2,100→ 16,944 total
Award
Alkermes plc.$ALKS
Restricted Stock Unit Award
2022-07-07+5,957→ 5,957 total
Award
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2022-07-07+11,554→ 11,554 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2022-06-16+7,250→ 7,250 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2022-06-14$27.19/sh−695→ 16,256 total
Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2022-06-14−7,585→ 0 total
Exercise/Conversion
Alkermes plc.$ALKS
Ordinary Shares
2022-06-14+7,585→ 16,951 total
Purchase
Alkermes plc.$ALKS
Ordinary Shares
2022-03-04$23.43/sh+427→ 9,366 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2021-12-02$22.11/sh−1,339→ 8,939 total
Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2021-12-02−5,578→ 0 total
Exercise/Conversion
Alkermes plc.$ALKS
Ordinary Shares
2021-12-02+5,578→ 10,278 total
Disposition to Issuer
Future Health ESG Corp.
Common stock, par value $0.0001 per share
2021-10-24−1,688→ 11,250 total
Disposition to Issuer
Future Health ESG Corp.
Common stock, par value $0.0001 per share
2021-10-24−1,689→ 11,262 total
Award
Axonics, Inc.
Common Stock
2021-10-22+2,261→ 14,844 total
Purchase
Future Health ESG Corp.
Warrant
2021-09-14$1.00/sh+27,351→ 27,351 total
Award
Alkermes plc.$ALKS
Non Qualified Stock Option (Right to Buy)
2021-06-14+15,677→ 15,677 total
Award
Alkermes plc.$ALKS
Restricted Stock Unit Award
2021-06-14+7,585→ 7,585 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2021-05-26+7,250→ 7,250 total
Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2021-05-20−6,104→ 0 total

Companies

Recent Filings

Address

C/O LYRA THERAPEUTICS, INC. 480 ARSENAL WAY

WATERTOWN, MA, 02472

View on SEC.gov